At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 20 enrolled
Drug / intervention
Buprenorphinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial of At-Home Versus In-Office Buprenorphine Induction
In Brief
A Phase 3 clinical trial evaluating Buprenorphine for Opioid-Related Disorders and Heroin Dependence. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The study will assess the effectiveness of at-home vs. in-office induction for patients entering buprenorphine maintenance at Associates in Internal Medicine (AIM) primary care clinic.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid-Related Disorders, Heroin Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2007
First PostedMay 2008
Primary CompletionAug 2008
Study CompletionApr 2010
TodayJul 2026
First PostedMay 26, 2008
Enrollment StartDec 1, 2007
Primary CompletionAug 1, 2008
Study CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 18.1 years ago
Interventions
Buprenorphinedrug
Dose is determined according to the participants' individual need.